Cargando…
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...
Autores principales: | Liu, Andy, Alalami, Huda, Fan, Xuemo, Patil, Chirag, Gill, Jaya M, Kesari, Santosh, Hu, Jethro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410685/ https://www.ncbi.nlm.nih.gov/pubmed/37435740 http://dx.doi.org/10.2217/cns-2022-0021 |
Ejemplares similares
-
Very long-term survival of an older glioblastoma patient after treatment with cilengitide: a case report
por: Alalami, Huda, et al.
Publicado: (2023) -
Activity of pemetrexed in pre-clinical chordoma models and humans
por: Kesari, Santosh, et al.
Publicado: (2023) -
Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma
por: Volpini, Matthew E., et al.
Publicado: (2022) -
Salvage chemotherapy for adults with relapsed or refractory lymphoma in Malawi
por: Kaimila, Bongani, et al.
Publicado: (2017) -
ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.
por: Choi, Chul Won, et al.
Publicado: (2002)